High rates of modifiable cancer risk factors present in Western HIV-positive patients
Tenofovir during pregnancy reduces risk of mother-to-child hepatitis B virus transmission
REP 2139 shows promise for people with hepatitis B and hepatitis delta co-infection
Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025
World Health Organization calls for ambitious global targets for viral hepatitis control
People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen
People with hepatitis B can safely use Truvada PrEP for HIV prevention
Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection
